From Congress to Clinic: A Post-ESMO Breast Cancer 2021 Update on Immune-Based Therapies in Triple-Negative Breast Cancer

Get up to speed on immune-based therapies for triple-negative breast cancer including the most clinically relevant data from ESMO Breast Cancer 2021 with this on-demand webcast and downloadable slides from a live CCO webinar.

Share

Program Content

Activities

Immune-Based Therapy in TNBC
From Congress to Clinic: A Post-ESMO Breast Cancer 2021 Update on Immune-Based Therapies in Triple-Negative Breast Cancer
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: June 02, 2021

Expires: June 01, 2022

Activities

Immunotherapy in TNBC
Immunotherapy in TNBC: Rationale and Current Clinical Standards
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 11, 2021

Expires: May 10, 2022

ADC in TNBC
Antibody–Drug Conjugates Targeting Cell Surface Receptors in TNBC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 11, 2021

Expires: May 10, 2022

Faculty

cover img faculity

Nadia Harbeck, MD, PhD

Full Professor
Director
Breast Center, LMU University Hospital
Ludwig-Maximilians University
Munich, Germany

cover img faculity

Ian E. Krop, MD, PhD

Associate Professor of Medicine
Harvard Medical School
Associate Chief, Division of Breast Oncology
Breast Oncology Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.